HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Natacha Germain Selected Research

Thinness

1/2023Association of gut-specific non-inflammatory T lymphocytes with chronic anorexia nervosa and constitutional thinness.
12/2021Underweight but not underfat: is fat-free mass a key factor in constitutionally thin women?
12/2021Is constitutional thinness really different from anorexia nervosa? A systematic review and meta-analysis.
11/2020Skeletal muscle of females and males with constitutional thinness: a low intramuscular lipid content and oxidative profile.
1/2016Interleukin-7 Plasma Levels in Human Differentiate Anorexia Nervosa, Constitutional Thinness and Healthy Obesity.
1/2015Neuropeptide Y and α-MSH circadian levels in two populations with low body weight: anorexia nervosa and constitutional thinness.
4/2009Ghrelin/obestatin ratio in two populations with low bodyweight: constitutional thinness and anorexia nervosa.
4/2007Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Natacha Germain Research Topics

Disease

11Anorexia Nervosa
12/2021 - 04/2007
8Thinness
01/2023 - 04/2007
5Malnutrition (Nutritional Deficiencies)
01/2015 - 01/2007
3Obesity
01/2023 - 01/2016
3Weight Gain
09/2022 - 05/2012
2COVID-19
01/2022 - 01/2021
2Type 2 Diabetes Mellitus (MODY)
01/2022 - 03/2018
2Weight Loss (Weight Reduction)
03/2018 - 01/2016
2Amenorrhea
01/2017 - 01/2014
1Morbid Obesity
01/2022
1Feeding and Eating Disorders (Eating Disorder)
12/2021
1Adrenocortical Hyperfunction (Adrenal Gland Hyperfunction)
01/2020
1Body Weight (Weight, Body)
01/2015
1Bulimia Nervosa
06/2010
1Starvation
06/2010
1Diabetic Retinopathy (Retinopathy, Diabetic)
11/2005
1Papillary Carcinoma
05/2004
1Carcinoma (Carcinomatosis)
05/2004
1Adenoma (Adenomas)
05/2004
1Lymphatic Metastasis
05/2004
1Papillary Thyroid Cancer
05/2004
1Neoplasms (Cancer)
05/2004
1Carcinogenesis
05/2004

Drug/Important Bio-Agent (IBA)

6GhrelinIBA
01/2016 - 04/2007
5LeptinIBA
12/2021 - 01/2007
2Biological ProductsIBA
09/2022 - 01/2014
2Appetite Depressants (Anorectics)IBA
12/2021 - 01/2015
2Glucagon-Like Peptide 1 (GLP 1)IBA
03/2018 - 04/2007
2Peptide YYIBA
01/2016 - 04/2007
2Insulin-Like Growth Factor I (IGF-1)IBA
05/2012 - 01/2007
2Hydrocortisone (Cortisol)FDA LinkGeneric
05/2012 - 05/2010
1CytokinesIBA
01/2023
1ProteomeIBA
09/2022
1Growth Hormone (Somatotropin)IBA
12/2021
1Insulin-Like PeptidesIBA
12/2021
1Estradiol (Delestrogen)FDA LinkGeneric
12/2021
1Follicle Stimulating Hormone (Follitropin)FDA Link
12/2021
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
12/2021
1Dipeptidyl-Peptidase IV InhibitorsIBA
01/2021
1LipidsIBA
11/2020
1Triglycerides (Triacylglycerol)IBA
11/2020
1Opioid Receptors (Opioid Receptor)IBA
01/2020
1Opioid Analgesics (Opioids)IBA
01/2020
1Insulin (Novolin)FDA Link
03/2018
1LiraglutideFDA Link
03/2018
1C-PeptideIBA
03/2018
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2017
1Interleukin-7 (Interleukin 7)IBA
01/2016
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
01/2015
1Melanocyte-Stimulating Hormones (MSH)IBA
01/2015
1Neuropeptide YIBA
01/2015
1Hormones (Hormone)IBA
01/2014
1NeuropeptidesIBA
06/2012
1Testosterone (Sustanon)FDA Link
05/2012
1inhibin BIBA
05/2012
1Gonadal Steroid Hormones (Sex Hormones)IBA
05/2012
1BP 16IBA
06/2010
1Peptides (Polypeptides)IBA
06/2010
1TropicamideFDA LinkGeneric
11/2005
1PPAR gammaIBA
05/2004
1RacivirIBA
05/2004

Therapy/Procedure

2Therapeutics
01/2017 - 05/2004
1Bariatric Surgery
01/2022
1Glycemic Control
03/2018
1Drug Therapy (Chemotherapy)
01/2017